  {"id":18345,"date":"2016-11-18T14:49:44","date_gmt":"2016-11-18T19:49:44","guid":{"rendered":"https:\/\/digital.hbs.edu\/platform-rctom\/submission\/fighting-counterfeit-drugs-one-text-at-a-time\/"},"modified":"2016-11-18T14:50:36","modified_gmt":"2016-11-18T19:50:36","slug":"fighting-the-counterfeit-drugs-market-one-text-at-a-time","status":"publish","type":"hck-submission","link":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/","title":{"rendered":"Fighting the counterfeit drugs market, one text at a time"},"content":{"rendered":"<p><strong>A market worth disrupting<\/strong><\/p>\n<p>In 2014, the global pharmaceutical market was estimated at $1.0 trillion and forecasted to grow to $1.3 trillion by 2018<a href=\"#_ftn1\" name=\"_ftnref1\">[1]<\/a>. The market for counterfeit drugs is estimated to be $75bn<a href=\"#_ftn2\" name=\"_ftnref2\">[2]<\/a>, so not an inconsequential percentage of a very large market. Deaths that arise as a result of patients taking fake drugs is the biggest negative effect of counterfeit drugs. Counterfeit drugs are more rampant in developing countries where regulation is not as robust. According to a 2005 World Bank report, for many people in poor countries with weak regulatory systems, the likelihood that they are buying fake or ineffective drugs can be as high as 50%<a href=\"#_ftn3\" name=\"_ftnref3\">[3]<\/a>. The number of incidences appear to be on the rise and is also becoming more rampant in developed countries as the internet has connected more buyers and sellers<a href=\"#_ftn4\" name=\"_ftnref4\">[4]<\/a>. In fact, the world health organization estimated that over half the internet medicines sold in 2008 were counterfeit<a href=\"#_ftn5\" name=\"_ftnref5\">[5]<\/a>.<\/p>\n<p>The global market for pharmaceuticals is incredibly intricate and comprises several entities in the supply chain. This makes it particularly susceptible for bad actors to insert themselves at different points in the chain<a href=\"#_ftn6\" name=\"_ftnref6\">[6]<\/a>. I would argue that there are many other points in the supply chain, beyond what the arrows indicate in figure 1, where counterfeit drugs could be inserted.<\/p>\n<p><a href=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-15-at-9.35.30-PM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-18214\" src=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-15-at-9.35.30-PM-300x208.png\" alt=\"screen-shot-2016-11-15-at-9-35-30-pm\" width=\"300\" height=\"208\" srcset=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-15-at-9.35.30-PM-300x208.png 300w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-15-at-9.35.30-PM-600x417.png 600w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-15-at-9.35.30-PM.png 708w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Figure 1<\/p>\n<p><strong>Technology is creating new business opportunities: Sproxil, Inc. <\/strong><\/p>\n<p>Enter Sproxil, Inc., a company founded in 2009 with the aim of \u201cempowering consumers to help combat drug counterfeiting with a simple text message<a href=\"#_ftn7\" name=\"_ftnref7\">[7]<\/a>.\u201d Sproxil empowers consumers by reducing the middlemen in the supply chain and giving them direct access to the manufacturer. It does this by using the cell phone which is accessible my millions of people, particularly in developing countries where the need is greatest. Sproxil developed a Mobile Product Authentication (MPA) technology that can easily and effectively identify fake drugs before consumers even leave the pharmacy.<\/p>\n<p><strong>How Sproxil Works<\/strong><\/p>\n<ul>\n<li>Consumers scratch a label on the packaging and text a set of unique numbers to a toll-free phone number to verify if a medicine is authentic (the number is identical on all cellular networks in a country).<\/li>\n<li>Customers instantaneously receive a text message back that indicates whether or not a drug is legitimate; saying \u201cYes, genuine\u201d or \u201cNo, fake\u201d.<\/li>\n<li>If a fake product is found, a consumer is given a hotline number to call in order to report the fake product, and the hotline operators then report it to the appropriate authorities in the country.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-18244\" src=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM-300x103.png\" alt=\"screen-shot-2016-11-16-at-4-10-40-pm\" width=\"300\" height=\"103\" srcset=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM-300x103.png 300w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM-768x264.png 768w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM-1024x352.png 1024w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM-600x206.png 600w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.10.40-PM.png 1558w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Figure 2<\/p>\n<p><strong>Case Study in Nigeria: Making the counterfeit drug industry unprofitable<\/strong><\/p>\n<p>Sproxil has partnered with large pharmaceutical companies like Novartis and Merck. In Nigeria, Sproxil partnered with BIOFEM Pharmaceuticals Ltd., an agent for Merck. In Nigeria, despite an overall increase in market share, sales through BIOFEM were falling as Illegal operations were leveraging BIOFEM\u2019s brand name and reputation. After partnering with Sproxil, In less than three months there were scratch labels on over a million sachets, reaching 25 million buyers. According to BIOFEM, it has seen a return on investment of over 1000% less than three months after implementing the service.<\/p>\n<p><a href=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.12.01-PM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-18255\" src=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.12.01-PM-300x254.png\" alt=\"screen-shot-2016-11-16-at-4-12-01-pm\" width=\"300\" height=\"254\" srcset=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.12.01-PM-300x254.png 300w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.12.01-PM-768x651.png 768w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.12.01-PM-600x509.png 600w, https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-16-at-4.12.01-PM.png 774w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Figure 3<\/p>\n<p>There are other ways that BIOFEM is using the information they are gathering through MPA technology to enhance their business. First, they are using it for sales forecasting, targeted marketing promotions, and customer education. Second, BIOFEM can track the specific mobile network associated with an incoming text message. BIOFEM can begin to identify areas of the country with possible counterfeit activity. Finally, BIOFEM can offer product discounts, distribute product updates, and communicate any other information the customer may need to know<a href=\"#_ftn1\" name=\"_ftnref1\">[8]<\/a>.<\/p>\n<p><strong>Sproxil is expanding into other industries<\/strong><\/p>\n<p>The simplicity of the technology makes Sproxil applicable in many other industries. The company is using its MPA technology in the agri-business industry in Kenya to help farmers verify their products<a href=\"#_ftn2\" name=\"_ftnref2\">[9]<\/a>. <strong>\u00a0<\/strong>Sproxil is solving a true market need and creating value for both consumers and other players in the supply chain.<\/p>\n<p><a href=\"#_ftnref1\" name=\"_ftn1\"><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>Word count: 792<\/p>\n<p>Figure 1 Source:\u00a0Degardin Klara, Roggo Yves &amp; Margot Pierre (2013). Understanding and fighting the medicine counterfeit market. Journal of Pharmaceutical and Biomedical Analysis, Volume 87, page. 170<\/p>\n<p>Figure 2 Source: www.sproxil.com<\/p>\n<p>Figure 3 source:\u00a0Sproxil Case Study: Biofem Pharmaceuticals Ltd. <a href=\"http:\/\/www.sproxil.com\">www.sproxil.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"#_ftnref1\" name=\"_ftn1\">[1]<\/a> Global pharma sales to reach $1.3 trillion. http:\/\/thomsonreuters.com\/en\/articles\/2015\/global-pharma-sales-reach-above-1-trillion.html<\/p>\n<p><a href=\"#_ftnref2\" name=\"_ftn2\">[2]<\/a> Sproxil Case Study: Biofem Pharmaceuticals Ltd. <a href=\"http:\/\/www.sproxil.com\/\">www.sproxil.com<\/a><\/p>\n<p><a href=\"#_ftnref3\" name=\"_ftn3\">[3]<\/a> HNP Brief #2 (March 2005). Pharmaceuticals: Counterfeits, Substandard Drugs and Drug Diversion. <a href=\"http:\/\/documents.worldbank.org\/curated\/en\/320051468135938535\/pdf\/321920HNPBrief120Pharmeceuticals.pdf\">http:\/\/documents.worldbank.org\/curated\/en\/320051468135938535\/pdf\/321920HNPBrief120Pharmeceuticals.pdf<\/a><\/p>\n<p><a href=\"#_ftnref4\" name=\"_ftn4\">[4]<\/a> Degardin Klara, Roggo Yves &amp; Margot Pierre (2013). Understanding and fighting the medicine counterfeit market. Journal of Pharmaceutical and Biomedical Analysis, Volume 87, page. 169<\/p>\n<p><a href=\"#_ftnref5\" name=\"_ftn5\">[5]<\/a> Degardin Klara, Roggo Yves &amp; Margot Pierre (2013). Understanding and fighting the medicine counterfeit market. Journal of Pharmaceutical and Biomedical Analysis, Volume 87, page. 170<\/p>\n<p><a href=\"#_ftnref6\" name=\"_ftn6\">[6]<\/a> Degardin Klara, Roggo Yves &amp; Margot Pierre (2013). Understanding and fighting the medicine counterfeit market. Journal of Pharmaceutical and Biomedical Analysis, Volume 87, page. 170<\/p>\n<p><a href=\"#_ftnref7\" name=\"_ftn7\">[7]<\/a> <a href=\"https:\/\/www.sproxil.com\/defender\/\">https:\/\/www.sproxil.com\/defender\/<\/a><\/p>\n<p>[8] Sproxil Case Study: Biofem Pharmaceuticals Ltd. <a href=\"http:\/\/www.sproxil.com\">www.sproxil.com<\/a><\/p>\n<p>[9] Sproxil Case Study: over 4,600 Kenyan farmers use mobile phones to avoid counterfeit products. www.sproxil.com<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sproxil is leveraging existing mobile phone technology in developing countries to empower customers to fight against the counterfeit drug market. <\/p>\n","protected":false},"author":2231,"featured_media":18346,"comment_status":"open","ping_status":"closed","template":"","categories":[92,1902,91,2582,400,1686],"class_list":["post-18345","hck-submission","type-hck-submission","status-publish","has-post-thumbnail","hentry","category-cellphone","category-kenya","category-mobile","category-mobile-phone-authentication","category-nigeria","category-pharmaceutical"],"connected_submission_link":"https:\/\/d3.harvard.edu\/platform-rctom\/assignment\/digitization-challenge-2016\/","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fighting the counterfeit drugs market, one text at a time - Technology and Operations Management<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fighting the counterfeit drugs market, one text at a time - Technology and Operations Management\" \/>\n<meta property=\"og:description\" content=\"Sproxil is leveraging existing mobile phone technology in developing countries to empower customers to fight against the counterfeit drug market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/\" \/>\n<meta property=\"og:site_name\" content=\"Technology and Operations Management\" \/>\n<meta property=\"article:modified_time\" content=\"2016-11-18T19:50:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-18-at-2.46.35-PM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"504\" \/>\n\t<meta property=\"og:image:height\" content=\"406\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/\",\"name\":\"Fighting the counterfeit drugs market, one text at a time - Technology and Operations Management\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2016\\\/11\\\/Screen-Shot-2016-11-18-at-2.46.35-PM.png\",\"datePublished\":\"2016-11-18T19:49:44+00:00\",\"dateModified\":\"2016-11-18T19:50:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2016\\\/11\\\/Screen-Shot-2016-11-18-at-2.46.35-PM.png\",\"contentUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2016\\\/11\\\/Screen-Shot-2016-11-18-at-2.46.35-PM.png\",\"width\":504,\"height\":406},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Submissions\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/submission\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Fighting the counterfeit drugs market, one text at a time\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/#website\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/\",\"name\":\"Technology and Operations Management\",\"description\":\"MBA Student Perspectives\",\"potentialAction\":[{\"@type\":\"性视界Action\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-rctom\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fighting the counterfeit drugs market, one text at a time - Technology and Operations Management","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/","og_locale":"en_US","og_type":"article","og_title":"Fighting the counterfeit drugs market, one text at a time - Technology and Operations Management","og_description":"Sproxil is leveraging existing mobile phone technology in developing countries to empower customers to fight against the counterfeit drug market.","og_url":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/","og_site_name":"Technology and Operations Management","article_modified_time":"2016-11-18T19:50:36+00:00","og_image":[{"width":504,"height":406,"url":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-18-at-2.46.35-PM.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/","url":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/","name":"Fighting the counterfeit drugs market, one text at a time - Technology and Operations Management","isPartOf":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/#primaryimage"},"image":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/#primaryimage"},"thumbnailUrl":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-18-at-2.46.35-PM.png","datePublished":"2016-11-18T19:49:44+00:00","dateModified":"2016-11-18T19:50:36+00:00","breadcrumb":{"@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/#primaryimage","url":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-18-at-2.46.35-PM.png","contentUrl":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-content\/uploads\/sites\/4\/2016\/11\/Screen-Shot-2016-11-18-at-2.46.35-PM.png","width":504,"height":406},{"@type":"BreadcrumbList","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/fighting-the-counterfeit-drugs-market-one-text-at-a-time\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3.harvard.edu\/platform-rctom\/"},{"@type":"ListItem","position":2,"name":"Submissions","item":"https:\/\/d3.harvard.edu\/platform-rctom\/submission\/"},{"@type":"ListItem","position":3,"name":"Fighting the counterfeit drugs market, one text at a time"}]},{"@type":"WebSite","@id":"https:\/\/d3.harvard.edu\/platform-rctom\/#website","url":"https:\/\/d3.harvard.edu\/platform-rctom\/","name":"Technology and Operations Management","description":"MBA Student Perspectives","potentialAction":[{"@type":"性视界Action","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3.harvard.edu\/platform-rctom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/hck-submission\/18345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/hck-submission"}],"about":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/types\/hck-submission"}],"author":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/users\/2231"}],"replies":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/comments?post=18345"}],"version-history":[{"count":0,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/hck-submission\/18345\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/media\/18346"}],"wp:attachment":[{"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/media?parent=18345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-rctom\/wp-json\/wp\/v2\/categories?post=18345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}